Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.7 HKD | -1.46% | -6.88% | +13.40% |
Business Summary
Number of employees: 432
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Drug
100.0
%
| 15 | 100.0 % | 139 | 100.0 % | +835.46% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China, Hong Kong and Macau
91.0
%
| - | - | 127 | 91.0 % | - |
Other Country
9.0
%
| 15 | 100.0 % | 13 | 9.0 % | -15.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Michael Berry
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-06-14 |
Jennifer Yang
CTO | Chief Tech/Sci/R&D Officer | 56 | 21-04-14 |
Xu Xin Liu
IRC | Investor Relations Contact | 40 | 21-09-30 |
Yang Shi
PRN | Corporate Officer/Principal | 48 | 19-01-31 |
Zhengying Zhu
PRN | Corporate Officer/Principal | 51 | 17-10-31 |
Xu Zhu
PRN | Corporate Officer/Principal | 54 | 17-09-30 |
Yee Wa Lau
SEC | Corporate Secretary | 52 | - |
Jason M. Brown
PRN | Corporate Officer/Principal | 52 | 17-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Fan Li
BRD | Director/Board Member | 55 | 20-08-31 |
Honggang Feng
BRD | Director/Board Member | 59 | Feb. 08 |
Wei Fu
CHM | Chairman | 42 | 17-06-30 |
Ki Chul Cho
BRD | Director/Board Member | 46 | Jan. 11 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Shi Dong Jiang
BRD | Director/Board Member | 57 | 20-08-31 |
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Hoi Yam Chui
BRD | Director/Board Member | 57 | 23-01-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 328,532,049 | 193,532,752 ( 58.91 %) | 4,348,701 ( 1.324 %) | 58.91 % |
Company contact information
Everest Medicines Ltd.
CITIC Pacific Plaza 1168 West Nanjing Road
200041, Shanghai
+
http://www.everestmedicines.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.40% | 983M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+51.96% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
-13.41% | 12.21B | |
+5.17% | 8.83B |
- Stock Market
- Equities
- 1952 Stock
- Company Everest Medicines Limited